Rapid Build of HIV Related Protective Barriers

NCT03852849 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

600

Enrollment

OTHER_GOV

Sponsor class

Conditions

Viral Suppression of HIV Infection

Interventions

BEHAVIORAL: Personal involved intervention strategies
DRUG: The dosage of 400mg EFV

Sponsor

National Center for AIDS/STD Control and Prevention, China CDC

Collaborators

[object Object]
[object Object]